Rapid, point‐of‐care antigen and molecular‐based tests for diagnosis of SARS‐CoV‐2 infection – Chochrane Library

We identified virtually no evidence for mass screening of asymptomatic individuals using rapid antigen tests in people with no known exposure. A small study screening travellers returning from high‐risk countries (Cerutti 2020), identified only five SARS‐CoV‐2 infections (prevalence of 3%) with a reported sensitivity of antigen testing for detecting infection of 40%. However, important larger studies have been published since the end of our search, as mentioned above.